PARTNER CONTENT
✕
ASIA

From natural health products to oil investment

BIOPROSPECT will become the latest in a string of biotech companies to diversify into oil and gas...

James McGrath

Under a heads of agreement signed recently, biotechnology company BioProspect will subscribe for $1 million of new shares in Frontier for a 25% stake, with an option to acquire an extra 50% in two tranches...

Start a free trial to continue reading this article

Already have an account?

Subscribe now
RELATED ARTICLES
MORE ON THIS TOPIC
MOST POPULAR
1
OIL & GAS

Woodside's Browse LNG project hinges on contentious carbon capture plans

2
EXPLORATION

NOPSEMA gives EOG green light to drill giant Beehive prospect

3
ENERGY TRANSITION

Is all that glitters really gold? Gold Hydrogen's escrow release looms as stock valuation declines

4
EXPLORATION

Landmark legal case lodged to protect NT water from fracking

RESEARCH

lock Premium subscribers only

View more

A growing series of reports, each focused on a key discussion point for the energy sector, brought to you by the Energy News Bulletin Intelligence team.

A growing series of reports, each focused on a key discussion point for the energy sector, brought to you by the Energy News Bulletin Intelligence team.

editions

Future of Energy Report: Nuclear Power in Australia 2024

Energy News Bulletin’s new report examines what the energy and resources industry thinks of the idea of a nuclear-powered Australia.

editions

ENB CCS Report 2024

ENB’s CCS Report 2024 finds that CCS could be the much-needed magic bullet for Australia’s decarbonisation drive

editions

ENB Cost Report 2023

ENB’s latest Cost Report findings provide optimism as investments in oil and gas, as well as new energy rise.

editions

ENB Future of Energy Report 2023

ENB’s inaugural Future of Energy Report details the industry outlook on the medium-to-long-term future for the sector in the Asia Pacific region.

Content
About
Solutions
Legal

THE ASPERMONT BRAND PORTFOLIO

Copyright © 2000-2024 Aspermont Ltd. All rights reserved. Aspermont Limited (ABN 66 000 375 048), PO Box 78, Leederville, Western Australia 6902

Login